Skip to main content
. 2012 Mar 20;54(1):16. doi: 10.1186/1751-0147-54-16

Figure 4.

Figure 4

PAE and PA-SME of orbifloxacin and enrofloxacin for P. aeruginosa 33. Pre: The time of beginning exposure to the fluoroquinolone at twice the MIC. Post: The time of discontinuing exposure to the fluoroquinolone at twice the MIC.